Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing

Surgical Neurology

Volumn 72, Issue SUPPL. 1, 2009, Pages

  Wang, Yilong ^a   Wu, Di ^a   Zhao, Xingquan ^a   Ma, Ruihua ^a   Guo, Xiangping ^b   Wang, Chunxue ^a   Liu, Liping ^a   Zhao, Weijiang ^c   Wang, Yongjun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Chinese Medical Association   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cerebrovascular diseases; Emergency medical service; Thrombolytic treatment

Indexed keywords

ALTEPLASE; UROKINASE;

ARTICLE; CHINA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; EMERGENCY WARD; FIBRINOLYTIC THERAPY; HEALTH CARE SYSTEM; HOSPITAL; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; STENT; STROKE; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; CHINA; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; FEMALE; FIBRINOLYTIC AGENTS; HEALTH CARE RATIONING; HEALTH CARE SURVEYS; HEALTH RESOURCES; HOSPITAL UNITS; HUMANS; MALE; MIDDLE AGED; RESOURCE ALLOCATION; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 67651154582     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2007.12.028     Document Type: Article

References (12)

1. Alberts M.J., Hademenos G., Latchaw R.E., et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 283 23 (2000) 3102-3109
2. Camilo O., and Goldstein L.B. Statewide assessment of hospital-based stroke prevention and treatment services in North Carolina: changes over the last 5 years. Stroke 34 12 (2003) 2945-2950
3. Dion J.E. Management of ischemic stroke in the next decade: stroke centers of excellence. J Vasc Interv Radiol 15 1 Pt 2 (2004) S133-S141
4. Goldstein L.B., Hey L.A., and Laney R. North Carolina stroke prevention and treatment facilities survey. Statewide availability of programs and services. Stroke 31 1 (2000) 66-70
5. Johnston S.C., Fung L.H., Gillum L.A., et al. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke 32 5 (2001) 1061-1068
6. Katzan I.L., Furlan A.J., Lloyd L.E., et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 283 9 (2000) 1151-1158
7. Kwan J., Hand P., and Sandercock P. Improving the efficiency of delivery of thrombolysis for acute stroke: a systematic review. QJM 97 5 (2004) 273-279
8. Ruland S., Gorelick P.B., Schneck M., et al. Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities. Stroke 33 5 (2002) 1334-1339
9. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 24 (1995) 1581-1587
10. Wattigney W.A., Croft J.B., Mensah G.A., et al. Establishing data elements for the Paul Coverdell National Acute Stroke Registry. Part 1: proceedings of an expert panel. Stroke 34 1 (2003) 151-156
11. Wilson E., Taylor G., Phillips S., et al. Creating a Canadian stroke system. CMAJ 164 13 (2001) 1853-1855
12. Wu G.X., Wu Z.S., Liu J., et al. Trends of stroke events during 15 years in Beijing (WHO-SINO-MONICA Project Studies). Chin J Contr Chron Non-commun Dis 9 (2001) 106-108